Evidence map›Paper›PMID 25916556›Full record

ArticleNature communications2015

A REDD1/TXNIP pro-oxidant complex regulates ATG4B activity to control stress-induced autophagy and sustain exercise capacity.

Shuxi Qiao, Michael Dennis, Xiufeng Song, Douangsone D Vadysirisack, Devika Salunke, Zachary Nash, Zhifen Yang, Marc Liesa, Jun Yoshioka, Shu-Ichi Matsuzawa and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed
15.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 191 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Resilience to diabetic retinopathy.Progress in retinal and eye research · 2024
    Review

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Shuxi Qiao1] Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA [2] Harvard Medical School, Boston, Massachusetts 02115, USA.
Michael DennisMassachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA.
Xiufeng Song1] Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA [2] Harvard Medical School, Boston, Massachusetts 02115, USA.
Douangsone D Vadysirisack1] Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA [2] Harvard Medical School, Boston, Massachusetts 02115, USA.
Devika SalunkeMassachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA.
Zachary NashMassachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA.
Zhifen YangSanford-Burnham Medical Research Institute, La Jolla, California 92037, USA.
Marc LiesaDepartment of Medicine, Evans Center, Mitochondria ARC, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Jun Yoshioka1] Harvard Medical School, Boston, Massachusetts 02115, USA [2] Regenerative Medicine Center, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Shu-Ichi MatsuzawaSanford-Burnham Medical Research Institute, La Jolla, California 92037, USA.
Orian S Shirihai1] Department of Medicine, Evans Center, Mitochondria ARC, Boston University School of Medicine, Boston, Massachusetts 02118, USA [2] Department of Clinical Biochemistry, Faculty of Medicine, Ben Gurion University of the Negev, Beer-Sheva 8410501, Israel.
Richard T Lee1] Harvard Medical School, Boston, Massachusetts 02115, USA [2] Regenerative Medicine Center, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
John C Reed1] Sanford-Burnham Medical Research Institute, La Jolla, California 92037, USA [2] Roche Pharmaceutical Research and Early Development, Basel 4070, Switzerland.
Leif W Ellisen1] Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA [2] Harvard Medical School, Boston, Massachusetts 02115, USA.
Massachusetts General Hospital · USHarvard University · USSanford Burnham Prebys Medical Discovery Institute · USBen-Gurion University of the Negev · ILBoston University · USBrigham and Women's Hospital · USRoche (Switzerland) · CH

Funding

Function and mechanism of REDD1 signaling to TSC1/2 and mTORC1R01CA122589 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI ELLISEN, LEIF W · 2007 to 2017
$3.2M
Diabetic Cardiomyopathy and the Alpha Arrestin ProteinsR01HL103582 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LEE, RICHARD T · 2010 to 2013
$1.7M
Feedback regulation of p53 through the REDD1 pathwayF32CA150633 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI VADYSIRISACK, DOUANGSONE DANG · 2010 to 2012
$159k
NCI NIH HHS F32 CA150633NCI NIH HHS R01 CA122589NHLBI NIH HHS R01 HL103582
6 · The paper itself

Abstract

Macroautophagy (autophagy) is a critical cellular stress response; however, the signal transduction pathways controlling autophagy induction in response to stress are poorly understood. Here we reveal a new mechanism of autophagy control whose deregulation disrupts mitochondrial integrity and energy homeostasis in vivo. Stress conditions including hypoxia and exercise induce reactive oxygen species (ROS) through upregulation of a protein complex involving REDD1, an mTORC1 inhibitor and the pro-oxidant protein TXNIP. Decreased ROS in cells and tissues lacking either REDD1 or TXNIP increases catalytic activity of the redox-sensitive ATG4B cysteine endopeptidase, leading to enhanced LC3B delipidation and failed autophagy. Conversely, REDD1/TXNIP complex expression is sufficient to induce ROS, suppress ATG4B activity and activate autophagy. In Redd1(-/-) mice, deregulated ATG4B activity and disabled autophagic flux cause accumulation of defective mitochondria, leading to impaired oxidative phosphorylation, muscle ATP depletion and poor exercise capacity. Thus, ROS regulation through REDD1/TXNIP is physiological rheostat controlling stress-induced autophagy.

Indexed as

AutophagyAnimalsAutophagy-Related ProteinsCarrier ProteinsCysteine EndopeptidasesEnergy MetabolismExercise ToleranceMice, Inbred C57BLMitochondriaOxidative StressReactive Oxygen SpeciesThioredoxinsTranscription FactorsAtg4b protein, mouseAutophagy-Related ProteinsCarrier ProteinsCysteine EndopeptidasesDdit4 protein, mouseReactive Oxygen SpeciesThioredoxinsTranscription FactorsTxnip protein, mouse

Identifiers

PMID25916556
PMCPMC4421852
OpenAlexW2032687345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.